{"title":"疾病发病时的症状可预测COVID-19疾病的预后。","authors":"Aiyuan Zhou, Qing Song, Yating Peng, Xin Liao, Peng Huang, Wenlong Liu, Zhi Xiang, Qimi Liu, Mingyan Jiang, Xudong Xiang, Dingding Deng, Ping Chen","doi":"10.1080/19932820.2021.2010338","DOIUrl":null,"url":null,"abstract":"<p><p>The main clinical manifestations of coronavirus disease 2019 (COVID-19) onset are respiratory symptoms, including cough, sputum, and dyspnea. However, a significant proportion of patients initially manifested non-respiratory symptoms, such as fever, myalgia, and diarrhea. Here, we compared the different characteristics and outcomes between the patients with respiratory symptoms and non-respiratory symptoms at illness onset. The patients admitted to the respiratory departments from eight hospitals in Hunan and Guangxi Province with nucleic acid-positive severe acute respiratory syndrome coronavirus (SARS-CoV-2) were recruited. Epidemiological information, clinical manifestations, laboratory findings, and radiological characteristics, treatment regimens, and outcomes data were recorded and analyzed. The median age of the recruited 541 subjects was 43 years (IQR, 33-55). Of the 541 subjects, 404 (74.5%) subjects had initial symptom that were respiratory, while 137 (25.5%) subjects had non-respiratory symptoms. Respiratory COVID-19 subjects had more secondary bacterial infections (8.7% vs 0.0%, <i>P</i> < 0.001), needed the intensive care unit more (9.7% vs 2.2%, <i>P</i> = 0.005), non-invasive ventilation more (7.2% vs 1.5%, <i>P</i> = 0.004), developed ARDS more (11.4% vs 2.2%, <i>P</i> = 0.001) and needed longer time to recover (18.5 vs 16.7 days, <i>P</i> = 0.003) compared to predominately non-respiratory COVID-19 subjects. The multivariate model showed that age (OR = 1.04, <i>P</i> = 0.01), dyspnea (OR = 4.91, <i>P</i> < 0.001) and secondary bacterial infection (OR = 19.8, <i>P</i> < 0.001) were independently associated with development of ARDS among COVID-19 patients. We identify COVID-19 subjects with dyspnea at disease onset who have a worse prognosis. We also demonstrate age and secondary bacterial infections to be independently associated with ARDS development in subjects with COVID-19.<b>ABBREVIATIONS</b>: COVID-19: Coronavirus disease 2019; ARDS: acute respiratory distress syndrome; IQR: interquartile range; ICU: intensive care unit; CDC: Chinese Center for Disease Control and Prevention.</p>","PeriodicalId":1,"journal":{"name":"Accounts of Chemical Research","volume":null,"pages":null},"PeriodicalIF":16.4000,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/fb/92/ZLJM_17_2010338.PMC8725726.pdf","citationCount":"5","resultStr":"{\"title\":\"Symptoms at disease onset predict prognosis in COVID-19 disease.\",\"authors\":\"Aiyuan Zhou, Qing Song, Yating Peng, Xin Liao, Peng Huang, Wenlong Liu, Zhi Xiang, Qimi Liu, Mingyan Jiang, Xudong Xiang, Dingding Deng, Ping Chen\",\"doi\":\"10.1080/19932820.2021.2010338\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>The main clinical manifestations of coronavirus disease 2019 (COVID-19) onset are respiratory symptoms, including cough, sputum, and dyspnea. However, a significant proportion of patients initially manifested non-respiratory symptoms, such as fever, myalgia, and diarrhea. Here, we compared the different characteristics and outcomes between the patients with respiratory symptoms and non-respiratory symptoms at illness onset. The patients admitted to the respiratory departments from eight hospitals in Hunan and Guangxi Province with nucleic acid-positive severe acute respiratory syndrome coronavirus (SARS-CoV-2) were recruited. Epidemiological information, clinical manifestations, laboratory findings, and radiological characteristics, treatment regimens, and outcomes data were recorded and analyzed. The median age of the recruited 541 subjects was 43 years (IQR, 33-55). Of the 541 subjects, 404 (74.5%) subjects had initial symptom that were respiratory, while 137 (25.5%) subjects had non-respiratory symptoms. Respiratory COVID-19 subjects had more secondary bacterial infections (8.7% vs 0.0%, <i>P</i> < 0.001), needed the intensive care unit more (9.7% vs 2.2%, <i>P</i> = 0.005), non-invasive ventilation more (7.2% vs 1.5%, <i>P</i> = 0.004), developed ARDS more (11.4% vs 2.2%, <i>P</i> = 0.001) and needed longer time to recover (18.5 vs 16.7 days, <i>P</i> = 0.003) compared to predominately non-respiratory COVID-19 subjects. The multivariate model showed that age (OR = 1.04, <i>P</i> = 0.01), dyspnea (OR = 4.91, <i>P</i> < 0.001) and secondary bacterial infection (OR = 19.8, <i>P</i> < 0.001) were independently associated with development of ARDS among COVID-19 patients. We identify COVID-19 subjects with dyspnea at disease onset who have a worse prognosis. We also demonstrate age and secondary bacterial infections to be independently associated with ARDS development in subjects with COVID-19.<b>ABBREVIATIONS</b>: COVID-19: Coronavirus disease 2019; ARDS: acute respiratory distress syndrome; IQR: interquartile range; ICU: intensive care unit; CDC: Chinese Center for Disease Control and Prevention.</p>\",\"PeriodicalId\":1,\"journal\":{\"name\":\"Accounts of Chemical Research\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":16.4000,\"publicationDate\":\"2022-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/fb/92/ZLJM_17_2010338.PMC8725726.pdf\",\"citationCount\":\"5\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Accounts of Chemical Research\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1080/19932820.2021.2010338\",\"RegionNum\":1,\"RegionCategory\":\"化学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CHEMISTRY, MULTIDISCIPLINARY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Accounts of Chemical Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/19932820.2021.2010338","RegionNum":1,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, MULTIDISCIPLINARY","Score":null,"Total":0}
引用次数: 5
摘要
2019冠状病毒病(COVID-19)发病的主要临床表现为呼吸道症状,包括咳嗽、痰、呼吸困难。然而,相当比例的患者最初表现为非呼吸道症状,如发烧、肌痛和腹泻。在这里,我们比较了发病时出现呼吸道症状和非呼吸道症状的患者的不同特征和结局。选取湖南、广西两省8家医院收治的冠状病毒(SARS-CoV-2)核酸阳性患者为研究对象。记录和分析流行病学信息、临床表现、实验室结果、放射学特征、治疗方案和结局资料。招募的541名受试者的中位年龄为43岁(IQR, 33-55岁)。在541名受试者中,404名(74.5%)受试者有呼吸道症状,137名(25.5%)受试者有非呼吸道症状。呼吸道COVID-19患者继发细菌感染较多(8.7% vs 0.0%, P = 0.005),无创通气较多(7.2% vs 1.5%, P = 0.004), ARDS发病较多(11.4% vs 2.2%, P = 0.001),恢复时间较长(18.5 vs 16.7天,P = 0.003)。多因素模型显示,年龄(OR = 1.04, P = 0.01)、呼吸困难(OR = 4.91, P PARDS:急性呼吸窘迫综合征;IQR:四分位间距;ICU:重症监护病房;中国疾病预防控制中心。
Symptoms at disease onset predict prognosis in COVID-19 disease.
The main clinical manifestations of coronavirus disease 2019 (COVID-19) onset are respiratory symptoms, including cough, sputum, and dyspnea. However, a significant proportion of patients initially manifested non-respiratory symptoms, such as fever, myalgia, and diarrhea. Here, we compared the different characteristics and outcomes between the patients with respiratory symptoms and non-respiratory symptoms at illness onset. The patients admitted to the respiratory departments from eight hospitals in Hunan and Guangxi Province with nucleic acid-positive severe acute respiratory syndrome coronavirus (SARS-CoV-2) were recruited. Epidemiological information, clinical manifestations, laboratory findings, and radiological characteristics, treatment regimens, and outcomes data were recorded and analyzed. The median age of the recruited 541 subjects was 43 years (IQR, 33-55). Of the 541 subjects, 404 (74.5%) subjects had initial symptom that were respiratory, while 137 (25.5%) subjects had non-respiratory symptoms. Respiratory COVID-19 subjects had more secondary bacterial infections (8.7% vs 0.0%, P < 0.001), needed the intensive care unit more (9.7% vs 2.2%, P = 0.005), non-invasive ventilation more (7.2% vs 1.5%, P = 0.004), developed ARDS more (11.4% vs 2.2%, P = 0.001) and needed longer time to recover (18.5 vs 16.7 days, P = 0.003) compared to predominately non-respiratory COVID-19 subjects. The multivariate model showed that age (OR = 1.04, P = 0.01), dyspnea (OR = 4.91, P < 0.001) and secondary bacterial infection (OR = 19.8, P < 0.001) were independently associated with development of ARDS among COVID-19 patients. We identify COVID-19 subjects with dyspnea at disease onset who have a worse prognosis. We also demonstrate age and secondary bacterial infections to be independently associated with ARDS development in subjects with COVID-19.ABBREVIATIONS: COVID-19: Coronavirus disease 2019; ARDS: acute respiratory distress syndrome; IQR: interquartile range; ICU: intensive care unit; CDC: Chinese Center for Disease Control and Prevention.
期刊介绍:
Accounts of Chemical Research presents short, concise and critical articles offering easy-to-read overviews of basic research and applications in all areas of chemistry and biochemistry. These short reviews focus on research from the author’s own laboratory and are designed to teach the reader about a research project. In addition, Accounts of Chemical Research publishes commentaries that give an informed opinion on a current research problem. Special Issues online are devoted to a single topic of unusual activity and significance.
Accounts of Chemical Research replaces the traditional article abstract with an article "Conspectus." These entries synopsize the research affording the reader a closer look at the content and significance of an article. Through this provision of a more detailed description of the article contents, the Conspectus enhances the article's discoverability by search engines and the exposure for the research.